Global Recombinant Protein Drugs Market Size, Share, Trends and Forecast 2020-2026

Description

This report focuses on Recombinant Protein Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Protein Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Recombinant DNA
Recombinant RNA

Segment by Application
Pharmaceutical Industry
Other

TABLE OF CONTENT

Table of Contents

1 Recombinant Protein Drugs Market Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Recombinant Protein Drugs Segment by Type
1.2.1 Global Recombinant Protein Drugs Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Recombinant DNA
1.2.3 Recombinant RNA
1.3 Recombinant Protein Drugs Segment by Application
1.3.1 Recombinant Protein Drugs Consumption Comparison by Application: 2020 VS 2026
1.3.2 Pharmaceutical Industry
1.3.3 Other
1.4 Global Recombinant Protein Drugs Market by Region
1.4.1 Global Recombinant Protein Drugs Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Recombinant Protein Drugs Growth Prospects
1.5.1 Global Recombinant Protein Drugs Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Recombinant Protein Drugs Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Recombinant Protein Drugs Production Estimates and Forecasts (2015-2026)

2 Market Competition by Manufacturers
2.1 Global Recombinant Protein Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Recombinant Protein Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Recombinant Protein Drugs Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Recombinant Protein Drugs Production Sites, Area Served, Product Types
2.6 Recombinant Protein Drugs Market Competitive Situation and Trends
2.6.1 Recombinant Protein Drugs Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion

3 Production Capacity by Region
3.1 Global Production Capacity of Recombinant Protein Drugs Market Share by Regions (2015-2020)
3.2 Global Recombinant Protein Drugs Revenue Market Share by Regions (2015-2020)
3.3 Global Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Recombinant Protein Drugs Production
3.4.1 North America Recombinant Protein Drugs Production Growth Rate (2015-2020)
3.4.2 North America Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Recombinant Protein Drugs Production
3.5.1 Europe Recombinant Protein Drugs Production Growth Rate (2015-2020)
3.5.2 Europe Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Recombinant Protein Drugs Production
3.6.1 China Recombinant Protein Drugs Production Growth Rate (2015-2020)
3.6.2 China Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Recombinant Protein Drugs Production
3.7.1 Japan Recombinant Protein Drugs Production Growth Rate (2015-2020)
3.7.2 Japan Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Recombinant Protein Drugs Consumption by Regions
4.1 Global Recombinant Protein Drugs Consumption by Regions
4.1.1 Global Recombinant Protein Drugs Consumption by Region
4.1.2 Global Recombinant Protein Drugs Consumption Market Share by Region
4.2 North America
4.2.1 North America Recombinant Protein Drugs Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Recombinant Protein Drugs Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Recombinant Protein Drugs Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Recombinant Protein Drugs Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil

5 Production, Revenue, Price Trend by Type
5.1 Global Recombinant Protein Drugs Production Market Share by Type (2015-2020)
5.2 Global Recombinant Protein Drugs Revenue Market Share by Type (2015-2020)
5.3 Global Recombinant Protein Drugs Price by Type (2015-2020)
5.4 Global Recombinant Protein Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Recombinant Protein Drugs Market Analysis by Application
6.1 Global Recombinant Protein Drugs Consumption Market Share by Application (2015-2020)
6.2 Global Recombinant Protein Drugs Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Recombinant Protein Drugs Business
7.1 Novo Nordisk
7.1.1 Novo Nordisk Recombinant Protein Drugs Production Sites and Area Served
7.1.2 Novo Nordisk Recombinant Protein Drugs Product Introduction, Application and Specification
7.1.3 Novo Nordisk Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Novo Nordisk Main Business and Markets Served
7.2 Amgen
7.2.1 Amgen Recombinant Protein Drugs Production Sites and Area Served
7.2.2 Amgen Recombinant Protein Drugs Product Introduction, Application and Specification
7.2.3 Amgen Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Amgen Main Business and Markets Served
7.3 Sanofi
7.3.1 Sanofi Recombinant Protein Drugs Production Sites and Area Served
7.3.2 Sanofi Recombinant Protein Drugs Product Introduction, Application and Specification
7.3.3 Sanofi Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Sanofi Main Business and Markets Served
7.4 Eli Lilly
7.4.1 Eli Lilly Recombinant Protein Drugs Production Sites and Area Served
7.4.2 Eli Lilly Recombinant Protein Drugs Product Introduction, Application and Specification
7.4.3 Eli Lilly Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Eli Lilly Main Business and Markets Served
7.5 Merck Serono
7.5.1 Merck Serono Recombinant Protein Drugs Production Sites and Area Served
7.5.2 Merck Serono Recombinant Protein Drugs Product Introduction, Application and Specification
7.5.3 Merck Serono Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Merck Serono Main Business and Markets Served
7.6 Ortho Biotech
7.6.1 Ortho Biotech Recombinant Protein Drugs Production Sites and Area Served
7.6.2 Ortho Biotech Recombinant Protein Drugs Product Introduction, Application and Specification
7.6.3 Ortho Biotech Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Ortho Biotech Main Business and Markets Served
7.7 Roche
7.7.1 Roche Recombinant Protein Drugs Production Sites and Area Served
7.7.2 Roche Recombinant Protein Drugs Product Introduction, Application and Specification
7.7.3 Roche Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 Roche Main Business and Markets Served
7.8 Kyowa Hakko Kirin
7.8.1 Kyowa Hakko Kirin Recombinant Protein Drugs Production Sites and Area Served
7.8.2 Kyowa Hakko Kirin Recombinant Protein Drugs Product Introduction, Application and Specification
7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Kyowa Hakko Kirin Main Business and Markets Served
7.9 Pharmingen
7.9.1 Pharmingen Recombinant Protein Drugs Production Sites and Area Served
7.9.2 Pharmingen Recombinant Protein Drugs Product Introduction, Application and Specification
7.9.3 Pharmingen Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Pharmingen Main Business and Markets Served
7.10 Abcam
7.10.1 Abcam Recombinant Protein Drugs Production Sites and Area Served
7.10.2 Abcam Recombinant Protein Drugs Product Introduction, Application and Specification
7.10.3 Abcam Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Abcam Main Business and Markets Served
7.11 GenSci
7.11.1 GenSci Recombinant Protein Drugs Production Sites and Area Served
7.11.2 GenSci Recombinant Protein Drugs Product Introduction, Application and Specification
7.11.3 GenSci Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 GenSci Main Business and Markets Served
7.12 SL PHARM
7.12.1 SL PHARM Recombinant Protein Drugs Production Sites and Area Served
7.12.2 SL PHARM Recombinant Protein Drugs Product Introduction, Application and Specification
7.12.3 SL PHARM Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 SL PHARM Main Business and Markets Served
7.13 Dongbao Pharm
7.13.1 Dongbao Pharm Recombinant Protein Drugs Production Sites and Area Served
7.13.2 Dongbao Pharm Recombinant Protein Drugs Product Introduction, Application and Specification
7.13.3 Dongbao Pharm Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Dongbao Pharm Main Business and Markets Served
7.14 Ankebio
7.14.1 Ankebio Recombinant Protein Drugs Production Sites and Area Served
7.14.2 Ankebio Recombinant Protein Drugs Product Introduction, Application and Specification
7.14.3 Ankebio Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 Ankebio Main Business and Markets Served
7.15 NCPC
7.15.1 NCPC Recombinant Protein Drugs Production Sites and Area Served
7.15.2 NCPC Recombinant Protein Drugs Product Introduction, Application and Specification
7.15.3 NCPC Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 NCPC Main Business and Markets Served
7.16 Heng Rui
7.16.1 Heng Rui Recombinant Protein Drugs Production Sites and Area Served
7.16.2 Heng Rui Recombinant Protein Drugs Product Introduction, Application and Specification
7.16.3 Heng Rui Recombinant Protein Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.16.4 Heng Rui Main Business and Markets Served

8 Recombinant Protein Drugs Manufacturing Cost Analysis
8.1 Recombinant Protein Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Recombinant Protein Drugs
8.4 Recombinant Protein Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Recombinant Protein Drugs Distributors List
9.3 Recombinant Protein Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast
11.1 Global Forecasted Production of Recombinant Protein Drugs (2021-2026)
11.2 Global Forecasted Revenue of Recombinant Protein Drugs (2021-2026)
11.3 Global Forecasted Price of Recombinant Protein Drugs (2021-2026)
11.4 Global Recombinant Protein Drugs Production Forecast by Regions (2021-2026)
11.4.1 North America Recombinant Protein Drugs Production, Revenue Forecast (2021-2026)
11.4.2 Europe Recombinant Protein Drugs Production, Revenue Forecast (2021-2026)
11.4.3 China Recombinant Protein Drugs Production, Revenue Forecast (2021-2026)
11.4.4 Japan Recombinant Protein Drugs Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast
12.1 Global Forecasted and Consumption Demand Analysis of Recombinant Protein Drugs
12.2 North America Forecasted Consumption of Recombinant Protein Drugs by Country
12.3 Europe Market Forecasted Consumption of Recombinant Protein Drugs by Country
12.4 Asia Pacific Market Forecasted Consumption of Recombinant Protein Drugs by Regions
12.5 Latin America Forecasted Consumption of Recombinant Protein Drugs
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Recombinant Protein Drugs by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Recombinant Protein Drugs by Type (2021-2026)
13.1.2 Global Forecasted Price of Recombinant Protein Drugs by Type (2021-2026)
13.2 Global Forecasted Consumption of Recombinant Protein Drugs by Application (2021-2026)
14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

Choose License Type

Checkout Inquiry Sample